Bayonet Pharmaceuticals

Chennai, India
Manufactures high-quality medicines with innovation, social responsibility, and global accessibility.

About Bayonet Pharmaceuticals

Bayonet Pharmaceuticals was a Healthcare company based in Chennai (India) by Manohar. It manufactures high-quality medicines with innovation, social responsibility, and global accessibility. It operates on a B2B model. Its Indian entity Bayonet Pharmaceuticals Private Limited reported revenue of β‚Ή1.29 Cr. The company is recorded as dissolved. Bayonet Pharmaceuticals offers products and services including Broxolite Syrup, Gatorab-DSR, and Gatopan-40. Its focus areas include Pharmaceuticals, Quality Assurance, Global Distribution and Drug Manufacturing. Similar companies include Akums, Jubilant Life Sciences and Nectar Lifesciences; 2 of its 3 listed similar companies have raised funding.

Company details

Bayonet Pharmaceuticals Private Limited, headquartered in Chennai, focuses on delivering affordable and effective medications through WHO-GMP approved plants that adhere to high standards like UK-MHRA. The company emphasizes scientific excellence, quality control, and social responsibility in healthcare. With branches in Thrissur, it develops innovative drugs for global markets, ensuring safety and efficacy while serving clients worldwide through rigorous research and development.

  • Headquarters Chennai, India
  • Founders Manohar
  • Sectors
    Healthcare
  • Email
    β€’β€’β€’β€’β€’β€’β€’β€’
  • Phone
    β€’β€’β€’β€’ β€’β€’β€’β€’
  • Website bayonetpharma.com
  • Social Facebook
  • Legal Name Bayonet Pharmaceuticals Private Limited
  • Date of Incorporation 24 Feb, 2014
  • Jurisdiction Chennai, Tamil Nadu, India
Key Metrics
  • Annual Revenue
    ₹1.29 Cr

    FY 2025 · +12% YoY

  • Net Loss
    -₹2 Lakh

    FY 2025 · -2% margin

  • EBITDA
    -₹16,635

    FY 2025 · 0% margin

Products & Services of Bayonet Pharmaceuticals

Bayonet Pharmaceuticals offers a comprehensive portfolio of products and services, including Broxolite Syrup, Gatorab-DSR, and Gatopan-40.

Broxolite Syrup
Syrup

Syrup medication for health treatment with high efficacy standards.

Gatorab-DSR
Tablet

Tablet for digestive health and relief purposes.

Gatopan-40
Tablet

Medication tablet for health management applications.

Board of directors of Bayonet Pharmaceuticals Private Limited (Bayonet Pharmaceuticals)

Bayonet Pharmaceuticals Private Limited is the primary company behind Bayonet Pharmaceuticals. The board of Bayonet Pharmaceuticals Private Limited currently have 6 directors; the longest-serving is Girisan Karankara, appointed in 2014. 6 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Girisan Karankara
DIN 06385583
Whole-time director24 Feb 201412 yrs 8 moBayonet Pharmaceuticals Private Limited
Mahesh Velayudhan Geetha
DIN 06769211
Whole-time director24 Feb 201412 yrs 8 moBayonet Pharmaceuticals Private Limited
Deepak Narayanan Nair
DIN 06769147
Whole-time director24 Feb 201412 yrs 8 moBayonet Pharmaceuticals Private Limited
Manoharan
DIN 06767443
Managing Director24 Feb 201412 yrs 8 moBayonet Pharmaceuticals Private Limited
Anosh Chandran
DIN 08059959
Whole-time director04 Jan 20197 yrs 10 moBayonet Pharmaceuticals Private Limited
Maju Gopinathan
DIN 08060025
Whole-time director04 Jan 20197 yrs 10 moBayonet Pharmaceuticals Private Limited

People of Bayonet Pharmaceuticals

1 people are tracked at Bayonet Pharmaceuticals (1 in leadership).

NameRoleGroup
Manohar
FounderLeadership
Premium access

Complete people profiles for Bayonet Pharmaceuticals

Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.

  • Full employee list
  • Team structure
  • Board tenure
  • Professional contacts

Verified entity values are shown only after access is granted.

Financials of Bayonet Pharmaceuticals

Figures of Bayonet Pharmaceuticals Private Limited, the primary company behind Bayonet Pharmaceuticals, for FY 2025. Revenue was ₹1.29 Cr (+12% year on year). Net loss was -₹2 Lakh (-2% margin). EBITDA was -₹16,635 (0% margin). Revenue has grown at a compounded annual rate of +15% over three years and +2% over five years.

  • ₹1.29 CrRevenue · FY 2025 · +12% YoY
  • -₹2 LakhNet loss · -2% margin
  • -₹16,635EBITDA · 0% margin
  • ₹10 LakhPaid-up capital
  • +15%Revenue CAGR, 3 years
  • +2%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bayonet Pharmaceuticals Private Limited are on its company page.

Premium access

Detailed financial statements for Bayonet Pharmaceuticals

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Similar companies to Bayonet Pharmaceuticals

Bayonet Pharmaceuticals has 3 listed similar companies in our database, 2 of them funded. They include Akums, Jubilant Life Sciences and Nectar Lifesciences.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
akums.in2004Delhi, India$70M395
CDMO focusing on spectrum of dosage forms and therapeutic segments
jubl.com1978Noida, India
Company offering a suite of R&D and manufacturing services for small molecules and generics
neclife.com1995Chandigarh, India$46.85M175
Cephalosporin APIs and generic formulations are manufactured.
Premium access

Detailed similar companies of Bayonet Pharmaceuticals

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Bayonet Pharmaceuticals

Bayonet Pharmaceuticals is headquartered in Chennai, India. It is registered at Chennai, Tamil Nadu, India.

The primary company behind Bayonet Pharmaceuticals, Bayonet Pharmaceuticals Private Limited, reported revenue of β‚Ή1.29 Cr for FY 2025, up 12% year on year.

Bayonet Pharmaceuticals Private Limited, headquartered in Chennai, focuses on delivering affordable and effective medications through WHO-GMP approved plants that adhere to high standards like UK-MHRA. The company emphasizes scientific excellence, quality control, and social responsibility in healthcare. With branches in Thrissur, it develops innovative drugs for global markets, ensuring safety and efficacy while serving clients worldwide through rigorous research and development.

Bayonet Pharmaceuticals's top competitors include Jubilant Life Sciences, Akums and Nectar Lifesciences.

Bayonet Pharmaceuticals offers Broxolite Syrup, Gatorab-DSR, and Gatopan-40.

Bayonet Pharmaceuticals operates through Bayonet Pharmaceuticals Private Limited.

The legal entities of Bayonet Pharmaceuticals currently have 6 directors, including Girisan Karankara, Mahesh Velayudhan Geetha, Deepak Narayanan Nair and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available